Please assess the completion status of the following clinical trial:

Trial Title: Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Healthy persons aged ≥ 18, and able to give informed consent~* Patient is admitted to hospital~* Primary reason for hospital admission is clinical suspicion of a new episode of ARI~* Onset of the following symptoms within the last 7 days: i. Sudden onset of self-reported fever OR temperature of ≥ 38°C at presentation AND ii. At least one respiratory symptom (cough, sore throat, runny or congested nose, dyspnoea) AND iii. At least one systemic symptom (headache, muscle ache, sweats or chills or tiredness).~Exclusion Criteria:~* Patient lacks capacity to provide informed consent~* Patient has been transferred from another hospital~* Patient has been previously enrolled in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).